Retinoblastoma is the most common eye tumour in children and usually occurs before the age of five. It can present in one eye or both, and doesn’t usually spread to other tissues.
The challenge for clinicians treating retinoblastoma is to prevent blindness and other serious effects of treatment that reduce life span or quality of life after treatment.
Treatment depends on the stage of the tumour, but can include surgery, chemotherapy, cryotherapy, light coagulation and radiation, with the eye spared whenever possible.
Symptoms can include: